Dosage strength is associated with medication persistence with Ginkgo biloba drug products: a cohort study of ambulatory drug claims data in Germany

BACKGROUND: Ginkgo biloba drugs (Gb) are reimbursed within the German statutory health insurance (SHI) scheme for treatment of dementia. In 2008, a novel Gb product containing 240 mg Ginkgo extract EGb761(®) per tablet was introduced aiming to facilitate medication use by incorporating the recommend...

Descripción completa

Detalles Bibliográficos
Autores principales: Czeche, Sittah, Schüssel, Katrin, Franzmann, Alexandra, Burkart, Martin, Schulz, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015864/
https://www.ncbi.nlm.nih.gov/pubmed/24156348
http://dx.doi.org/10.1186/1472-6882-13-278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015864/
https://www.ncbi.nlm.nih.gov/pubmed/24156348
http://dx.doi.org/10.1186/1472-6882-13-278

Ejemplares similares